Shingo Matsumoto

Title: Shingo Matsumoto: Innovator in Tumor Treatment and Oxygen Imaging

Introduction

Shingo Matsumoto is a notable inventor based in Rockville, MD (US), recognized for his contributions to the fields of tumor treatment and oxygen imaging. With a total of 2 patents, Matsumoto has made significant strides in enhancing the efficacy of hypoxia-activated prodrugs and developing advanced imaging systems.

Latest Patents

Matsumoto's latest patents include innovative methods for treating tumors. One patent focuses on the use of pyruvate or succinate to enhance the efficacy of hypoxia-activated prodrugs. This method involves administering a therapeutically effective amount of a hypoxia-sensitive agent alongside a pOlowering agent to improve treatment outcomes. Another patent details quantitative oxygen imaging systems and methods using echo-based single point imaging (ESPI). This system provides high-resolution oxygen images by employing spin echo detection and Single Point Imaging for spatial encoding of oxygen concentration, effectively eliminating artifacts associated with magnetic susceptibility.

Career Highlights

Throughout his career, Matsumoto has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and the H. Lee Moffitt Cancer Center and Research Institute, Inc. His work in these institutions has contributed to advancements in cancer research and treatment methodologies.

Collaborations

Matsumoto has collaborated with esteemed colleagues such as James B. Mitchell and Murali Krishna Cherukuri, further enhancing the impact of his research and innovations.

Conclusion

Shingo Matsumoto's work exemplifies the intersection of innovation and healthcare, particularly in the treatment of tumors and the development of imaging technologies. His contributions continue to influence the fields of medicine and research, showcasing the importance of inventive solutions in addressing complex health challenges.